inTest Raises Q2 Prelim Sales Guidance from $32.000M-$34.000M to $35.000M vs $33.013M Est

Benzinga Newsdesk www.benzinga.com Positive 92.1%

Neg 0% Neu 0% Pos 92.1%

inTest (AMEX:INTT) raises Q2 Prelim sales outlook from $32.000 million-$34.000 million to $35.000 million vs $33.013 million estimate.